KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

Men Most at RiskNew data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have doubled worldwide, and it now affects more than 800 ...